相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization
Mikael Croyal et al.
ANALYTICAL BIOCHEMISTRY (2011)
Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS Diseases
Rita Raddatz et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease
I. Arnulf
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain Clinical Implications
Nora D. Volkow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Decreased CSF Histamine in Narcolepsy With and Without Low CSF Hypocretin-1 in Comparison to Healthy Controls
Seiji Nishino et al.
SLEEP (2009)
Refined Docking as a Valuable Tool for Lead Optimization: Application to Histamine H3 Receptor Antagonists
Nicolas Levoin et al.
ARCHIV DER PHARMAZIE (2008)
Histamine H3 Receptor Antagonists Go to Clinics
Kerstin Sander et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Histamine H3 antagonists as wake-promoting and pro-cognitive agents
Emily M. Stocking et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy:: Studies in orexin-/- mice and patients
Jian-Sheng Lin et al.
NEUROBIOLOGY OF DISEASE (2008)
Histamine in the nervous system
Helmut L. Haas et al.
PHYSIOLOGICAL REVIEWS (2008)
Brain histamine and schizophrenia:: Potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649
Xavier Ligneau et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Histamine H3 receptor antagonists:: From target identification to drug leads
P. Bonaventure et al.
BIOCHEMICAL PHARMACOLOGY (2007)
BF2.649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H-3 receptor: Preclinical pharmacology
X. Ligneau et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Excessive daytime sleepiness in parkinsonism
I Arnulf
SLEEP MEDICINE REVIEWS (2005)
Perspectives on cognitive domains, H3 receptor ligands and neurological disease
AA Hancock et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders
MB Passani et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Application of genomics to drug design:: the example of the histamine H3 receptor
JC Schwartz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Arousal effect of orexin A depends on activation of hte histmic system
ZL Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease
OV Anichtchik et al.
NEUROBIOLOGY OF DISEASE (2001)
High constitutive activity of native H3 receptors regulates histamine neurons in brain
S Morisset et al.
NATURE (2000)
Distinct pharmacology of rat and human histamine H3 receptors:: role of two amino acids in the third transmembrane domain
X Ligneau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons
JS Lin
SLEEP MEDICINE REVIEWS (2000)
分享论文
